Hers vs Hone Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Hers and Hone Health are tied at 7.3/10. Hers is more affordable at $199/mo vs $309/mo. Choose Hers for women who want brand-name wegovy (injection or pill) at $149. Choose Hone Health for users who want a full-service health platform covering weigh.

A side-by-side comparison of Hers and Hone Health covering pricing, scores, medication types, insurance, and more to help you decide.

Hers

#35 of 48

7.3/10

The women's health arm of Hims & Hers Health (NYSE: HIMS). In 2026 Hers signed a direct Novo Nordisk partnership adding FDA-approved Wegovy (pen and pill) at $149/mo and Zepbound via the Lilly partnership — alongside their existing compounded semaglutide and new compounded tirzepatide programs.

Visit Hers

Hone Health

#39 of 48

7.3/10

Comprehensive men's health platform that includes GLP-1 medications alongside hormone optimization and lab testing.

Visit Hone Health

Feature	Hers	Hone Health
Our Score	7.3/10	7.3/10
Starting Price	$199/mo	$309/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Women who want brand-name Wegovy (injection or pill) at $149/mo via the 2026 Novo Nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand	Users who want a full-service health platform covering weight loss plus hormones and labs
Ranking	#35	#39

Pros & Cons Compared

Hers

Pros

+2026 Novo Nordisk partnership — FDA-approved Wegovy pen and Wegovy oral pill from $149/mo, one of the lowest brand-name GLP-1 prices on the market
+Zepbound access via the Lilly/Hims-Hers partnership announced 2026
+Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
+Broader women's health platform — integrates weight loss with hormonal, skin, and wellness services

Cons

−Membership + medication are billed separately ($39 first month / $149 ongoing membership) — watch the all-in math
−Generic support experience — large patient volume means less personalized attention
−Compounded pricing starts at $199/mo but stepped pricing applies at higher doses
−Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership — read as access, not value

Hone Health

Pros

+40+ biomarker lab panel included — the most comprehensive baseline testing of any GLP-1 telehealth provider
+Full health optimization platform covering hormones, longevity, and metabolic health beyond just weight loss
+Starts patients on gentler liraglutide before escalating — reduces first-week side effect severity
+Both compounded and potentially brand-name GLP-1 options available depending on clinical assessment

Cons

−Layered pricing: $65 initial consult + $149/mo membership + medication cost = $300-650/mo total — one of the most expensive options
−Select state availability — not available nationwide, and coverage varies by specific treatment program
−The $149/mo membership fee is required even before you can purchase any medication

Our Verdict

Hers and Hone Health are closely matched with identical scores of 7.3/10. If budget is your priority, Hers starts at $199/mo compared to Hone Health's $309/mo. Hers offers both brand-name and compounded medications, giving you more flexibility. Choose Hers if you want: women who want brand-name wegovy (injection or pill) at $149/mo via the 2026 novo nordisk partnership, or a compounded semaglutide option from a publicly traded telehealth brand. Choose Hone Health if you want: users who want a full-service health platform covering weight loss plus hormones and labs.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Hers nor Hone Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review